Flying in the face of convention, a new study claims daily intake of aspirin may do more harm than good for most people, more specifically middle-aged women.
Women aged 65 and above stand to gain from the benefits of non-steroid anti-inflammatory drugs, through lowered risk of stroke, heart attacks and certain cancers. In younger women greater risk of gastrointestinal bleeding outweighs any benefits, the study found.
Researchers concluded that evidence in favour of aspirin was lacking to show daily intake could lower incidence of heart disease and cancer. Thus, a blanket recommendation to take aspirin cannot be justified, though studies in the past have shown aspirin can indeed cut down risks. Medical associations across the globe only recommend the drug in high risk groups with blood clotting disorders.